K&G Techlaw Partners advises corporations, healthcare and pharmaceutical companies, multinational enterprises, investors, and senior executives on anti-bribery, anti-corruption, corporate investigations, financial crime, and regulatory enforcement matters.
Our team has experience advising on matters involving the Prevention of Corruption Act, Prevention of Money Laundering Act, cross-border investigations under the U.S. Foreign Corrupt Practices Act and UK Bribery Act, third-party compliance reviews, healthcare-sector investigations, and enterprise-wide ethics and compliance programmes.
We assist clients in navigating complex corruption risks, responding to regulatory investigations, conducting internal reviews, implementing effective compliance frameworks, and strengthening corporate governance systems. By combining litigation, investigations, regulatory, and compliance expertise, we help organizations build resilient and globally aligned ethics programmes while effectively managing enforcement and reputational risks.
Core Capabilities
- Prevention of Corruption Act Advisory
- Prevention of Money Laundering Act Matters
- Corporate Investigations & Fact-Finding Reviews
- FCPA & UK Bribery Act Compliance
- CBI & Regulatory Investigations
- Pharmaceutical & Healthcare Compliance
- CME and HCP Engagement Reviews
- Third-Party ABAC Due Diligence
- Vendor Integrity Assessments
- Anti-Bribery Policies & SOPs
- Ethics & Compliance Programme Implementation
- Global ABAC Policy Localization
- Employee Training & Certification
- Patiala House & Rouse Avenue Court Representation
- Regulatory Defence & White-Collar Crime Advisor